These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18022045)

  • 1. Access to HAART and utilization of inpatient medical hospital services among HIV-infected patients with co-occurring serious mental illness and injection drug use.
    Himelhoch S; Chander G; Fleishman JA; Hellinger J; Gaist P; Gebo KA
    Gen Hosp Psychiatry; 2007; 29(6):518-25. PubMed ID: 18022045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use.
    Chander G; Himelhoch S; Fleishman JA; Hellinger J; Gaist P; Moore RD; Gebo KA
    AIDS Care; 2009 May; 21(5):655-63. PubMed ID: 19444675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts.
    McGowan CC; Weinstein DD; Samenow CP; Stinnette SE; Barkanic G; Rebeiro PF; Sterling TR; Moore RD; Hulgan T
    PLoS One; 2011 Apr; 6(4):e18462. PubMed ID: 21541016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cerebrovascular events in persons with and without HIV: a Danish nationwide population-based cohort study.
    Rasmussen LD; Engsig FN; Christensen H; Gerstoft J; Kronborg G; Pedersen C; Obel N
    AIDS; 2011 Aug; 25(13):1637-46. PubMed ID: 21646903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.
    Fleishman JA; Gebo KA; Reilly ED; Conviser R; Christopher Mathews W; Todd Korthuis P; Hellinger J; Rutstein R; Keiser P; Rubin H; Moore RD;
    Med Care; 2005 Sep; 43(9 Suppl):III40-52. PubMed ID: 16116308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-related medical service use by rural/urban residents: a multistate perspective.
    Wilson LE; Korthuis T; Fleishman JA; Conviser R; Lawrence PB; Moore RD; Gebo KA
    AIDS Care; 2011 Aug; 23(8):971-9. PubMed ID: 21400307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states.
    Gebo KA; Fleishman JA; Moore RD
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):609-16. PubMed ID: 16284539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of alcohol abuse and injection drug use with immunologic and virologic responses to HAART in HIV-positive patients from urban community health clinics.
    Henrich TJ; Lauder N; Desai MM; Sofair AN
    J Community Health; 2008 Apr; 33(2):69-77. PubMed ID: 18046634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital and outpatient health services utilization among HIV-infected children in care 2000-2001.
    Rutstein RM; Gebo KA; Siberry GK; Flynn PM; Spector SA; Sharp VL; Fleishman JA
    Med Care; 2005 Sep; 43(9 Suppl):III31-9. PubMed ID: 16116307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
    Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
    J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
    Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
    HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
    Gebo KA; Fleishman JA; Conviser R; Reilly ED; Korthuis PT; Moore RD; Hellinger J; Keiser P; Rubin HR; Crane L; Hellinger FJ; Mathews WC;
    J Acquir Immune Defic Syndr; 2005 Jan; 38(1):96-103. PubMed ID: 15608532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active injection drug-abuse offsets healthcare engagement in HIV-infected patients.
    Liappis AP; Laake AM; Delman M
    AIDS Behav; 2015 Jan; 19(1):81-4. PubMed ID: 24710959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV patients with psychiatric disorders are less likely to discontinue HAART.
    Himelhoch S; Brown CH; Walkup J; Chander G; Korthius PT; Afful J; Gebo KA
    AIDS; 2009 Aug; 23(13):1735-42. PubMed ID: 19617816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons.
    Turner BJ; Fleishman JA; Wenger N; London AS; Burnam MA; Shapiro MF; Bing EG; Stein MD; Longshore D; Bozzette SA
    J Gen Intern Med; 2001 Sep; 16(9):625-33. PubMed ID: 11556944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals.
    Tegger MK; Crane HM; Tapia KA; Uldall KK; Holte SE; Kitahata MM
    AIDS Patient Care STDS; 2008 Mar; 22(3):233-43. PubMed ID: 18290749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active antiretroviral therapy and hospital readmission: comparison of a matched cohort.
    Nosyk B; Sun H; Li X; Palepu A; Anis AH
    BMC Infect Dis; 2006 Oct; 6():146. PubMed ID: 17022826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.